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The validity of rodent tumor end points in assessing the potential hazards of chemical exposure to
humans is a somewhat controversial but very important issue since most chemicals are classified as
potentially hazardous to humans on the basis of long-term carcinogenesis studies in rodents. The
ability to distinguish between genotoxic, cytotoxic, or receptor-mediated promotion effects of chemical
treatment would aid in the interpretation of rodent carcinogenesis data. Activated oncogenes in spon-
taneously occurring and chemically induced rodent tumors were examined and compared as one
approach to determine the mechanism by which chemical treatment caused an increased incidence of
rodent tumors. Different patterns of activated oncogenes were found not only in spontaneous versus
chemically induced mouse liver tumors but also in a variety of spontaneous rat tumors versus
chemically induced rat lung tumors. In the absence of cytotoxic effects, it could be argued that the
chemicals in question activated protooncogenes by a direct genotoxic mechanism. These results
provided a basis for the analysis of activated oncogenes in spontaneous and chemically induced
rodent tumors to provide information at a molecular level to aid in the extrapolation of rodent carcino-
genesis data to human risk assessment.
Introduction
Several approaches have been used to identify en-
vironmental agents posing significant carcinogenic
hazards to man. These include in vitro assays for mu-
tagenesis and in vivo tumorigenicity assays. How-
ever, most chemicals are classified as potentially haz-
ardous to humans on the basis of long-term carcino-
genesis studies in rodents. While these rodent carcin-
ogenesis studies are designed to mimic the route of
human exposure in the environment or workplace,
the dose of a given chemical is usually higher than
that which actually occurs in human exposure. The
extrapolation of rodent carcinogenic data to human
risk is therefore complicated by the higher doses of
chemicals that are employed in the rodent bioassays,
especially in the absence of information regarding the
mechanism(s) of tumor induction. Another com-
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plicating factor in the interpretation of rodent car-
cinogenic data is the appearance of species- and strain-
specific spontaneously occurring tumors in rodents
that are used in the bioassays.
Increasing evidence suggests that a small set of cel-
lular genes appear to be targets for genetic alterations
that contribute to the neoplastic transformation of cells.
These genes, termed protooncogenes, were initially
discovered as the transduced oncogenes of acute trans-
forming retroviruses (1). Recent studies have estab-
lished that protooncogenes can also be activated as on-
cogenes by mechanisms independent of retroviral in-
volvement. These mechanisms include point muta-
tions or gross DNA rearrangements such as translo-
cations or gene amplifications (1,2). Protooncogenes
appear to play a crucial role in normal cellular growth
and/or differentiation since they are highly con-
served in nature, being detected in species as divergent
as yeast, Drosophila, and humans.
The activation of protooncogenes in spontaneous
and chemically induced tumors has been studied in
great detail during the past several years. The number
of protooncogenes that must be activated in the mul-REYNOLDS ETAL.
Table 1. Activated oncogenes in liver tumors of the B6C3F1 mouse.
()0icogcles detected(
Ha-ras
Tranisfectioni frequncicy
Treatmienit ttumiorsl)ositive/tuimors teste(d Co(lon 61 mutattion Not co(doin 61 mutation Ki-ras raf tJnknown
Velhicle 17/27 15 - 1 l
Chlemiiicafl 26/45 1 1 8 3 1 3
tistep process of carcinogenesis is unclear at present
although the coincerte(d expression of at least two onco-
geines, ras an(l myc, are neededl for the transformation
of a primary cell in vitro (3). Also, in addlition to the
activation of protooncogenes, the loss of specific regu-
latory functioils such as tumnor suppressor genes may
be a (listiinct step inl neoplastic transformation (4).
Investigatioins in ro(lent mo(lels for chemical car-
ciinogeniesis imply that oncogenes are activated by
carciilogein treatimient ancl that this activation process
is an early evenit in tumor in(luction (5-7). These
finidiings suggest that one approach to (letermine the
Im echanIismil(s) by which a chenmical causes an in-
creased incidence of tumliors in a rodent bioassay is to
compare oncogeine activation in sponitaneous and
cheimiically in(lucedl tumuors. If the activated oncogenes
(letected in chemically indlucedl tumors were different
from those foundl in spontaneous tumors, then one
coul(l argue that the chemical activated the proto-
oncogene by a genotoxic imiechanism. Alternatively, the
(letectioni of similar activatiing lesions in oncogeines of
spontaneous andl chemically inducecd tumnors could
imlply that the chemical was increasing the spon-
taneous tumor incidence by a mnechanism such as
cytotoxicity or receptor-ime(licated promotion.
This paper will discuss the cletection of activated on-
cogeines in spontaneous and chemically induced tu-
mnors of the B6C3F1 mouse and the Fischer 344/N rat,
two species used extensively in National 'oxicology
Program/National Caincer Institute (NTP/NCI) car-
cinogenesis stu(lies. I'he implications of activated
oncogenes in these rodent tumors will also be discussed
in terms of the extrapolatioin of rodent carcinogenic
data to human risk assessimient
Activated Oncogenes in Liver
Tumors of the B6C3F1 Mouse
DNA transfectioin analysis of a series of spontaneous
(8,9) andl chemically induced (10) liver tumors
showed oncogene activation in both beinign and
malignant tumors. Southern blot analysis indicated a
high incidlence of Ha-ras gene activation in both the
spontaneous (9) and chemically induced (10) liver
tumors. Activated Ki-ras genes were detected in the
chemically indlucedl liver tumors but not in the spon-
taneous liver tumors (9,10). Also, raf oncogenes andl
non-ras oncogenes were (letected in both the spon-
taneous an(l cheimically indluce(d liver tumors (9,10).
Oligonucleotide analysis indicated that all of the Ha-
ras oncogeines detected in spontaneous liver tumors
were activated by point mutations in codon 61 whereas
the Ha-ras oncogenes detected in the chemically
induced liver tumors were activated by poinlt muta-
tion at a number of different codons (10). The detection
and analysis of activated oncogenes in mouse liver
tumors is summarized in Table 1.
Activated Oncogenes in Tumors of
the Fischer 344/N Rat
In contrast to the results obtained with the spon-
taneous mouse liver tumors, oncogenes detectable by
transfection analysis were absent in 9 malignant and
20 benign spontaneous nonliver tumors of the Fischer
344/N rat. These tumors included 8 mammary ade-
nomas or fibroadenomas, 5 testicular interstitial cell
adenomas, 4 subcutaneous fibromas or fibroadenomas,
3 mononuclear cell leukemias, 2 fibrosarcomas, and a
single adrenal pheochromocytoma, mammary adlen-
ocarcinoma, pancreatic acinar adenoma, pancreatic
islet cell adenoma, pituitary adenoma, splenic he-
mangiosarcoma, and prostatic adenocarcinoma (9).
I)NA transfection analysis of a series of rat luing
tumors, generated in a recent long-term carcinogen-
esis stu(ly conducted by NTP, indlicated that 18 of 19
tumors contained detectable oncogenes. Southern blot
and oligonucleotide analysis indicated that all of the
rat lung tumors contained an activated Ki-ras gene
with a GGT --( GAT mutation in codon 12 (1]). The
detection of activatecd oncogenes in rat tumors is
sutimmarize(l in ITable 2.
Interpretation of Rodent
Carcinogenesis Data and Its
Implications for Human Risk
Assessment
The regulation of humain exposure to a chemical,
basedl oIn long-term carcinogenesis studlies in rodents,
shouldl take into account whether the chemiiical in
questioin is mutagenic, cytotoxic, or has a receptor-
me(liate(d mechaniismii of promiiotion. Oincogene analy-
sis of tumliors from sponitaneous origin and( froIm long-
termii carcinogenesis stu(lies can be useful in several
ways. Investigationi of oncogene activationi in tuimlors
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Table 2. Activated oncogenes in tumors
ofthe Fischer 344/N rat.
Oncogenes detected,
Ki-ras
Transfection frequency
Treatment tumors positive/tumors tested Codon 12 mutation
Vehicle 0/29
Chemical 18/19 18
will allow an analysis of the mechanism of tumor for-
mation at a molecular level. For instance, the finding
of activating mutations in different codons of the Ha-
ras gene in chemically induced liver tumors versus
finding activating mutations in only one codon of the
Ha-ras gene in spontaneous liver tumors could, in the
absence ofany cytotoxic effects, be used to argue that the
chemical itself activated the Ha-ras protooncogene by a
genotoxic event. Likewise, different patterns of onco-
gene activation in spontaneous versus chemically
induced rat tumors would also be helpful in the clas-
sification of a rodent carcinogen as an initiator, pro-
moter, or cytotoxic chemical. This type of analysis
might be of particular importance for compounds
which are negative for mutagenicity on short-term
tests but which are positive for carcinogenicity in
long-term bioassays. Knowledge of the mechanisms by
which chemicals induce tumors in long-term rodent
bioassays may remove some of the uncertainty of low-
dose and species-to-species extrapolation of human risk
from rodent carcinogenesis data.
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